SuperworthRocket Pharmaceuticals shares outstanding RCKT
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jun 30, 2026
- 114.5M
- On a year earlier
- +3.1%
- more shares
Rocket Pharmaceuticals had 114.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 3.1% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 111.8M | +15% |
| FY2024 | 97.5M | +4% |
| FY2023 | 93.3M | +22% |
| FY2022 | 76.3M | +18% |
| FY2021 | 64.4M | +14% |
| FY2020 | 56.3M | +10% |
| FY2019 | 51.2M | +23% |
| FY2018 | 41.7M | +513% |
| FY2017 | 6.8M | +1% |
| FY2016 | 6.7M | +2% |
| FY2015 | 6.6M | +2489% |
| FY2014 | 255K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 114.5M | +3% | |
| Q1 FY26 | 112.1M | +2% | |
| Q4 FY25 | 111.8M | +15% | |
| Q3 FY25 | 111.6M | +18% | |
| Q2 FY25 | 111M | +18% | |
| Q1 FY25 | 110.1M | +18% | |
| Q4 FY24 | 97.5M | +4% | |
| Q3 FY24 | 94.2M | +14% | |
| Q2 FY24 | 93.7M | +16% | |
| Q1 FY24 | 93.5M | +18% | |
| Q4 FY23 | 93.3M | +22% | |
| Q3 FY23 | 82.6M | +25% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Rocket Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.